APA (7th ed.) Citation

J, M., R, M., T, R., A, M., JC, B., TM, L., & KM, B. (2025). Dupilumab Treatment for Aspirin-Exacerbated Respiratory Disease in a Real-World Setting: Impact on Quality of Life and Healthcare Utilization. American journal of rhinology & allergy, 39(2), 90. https://doi.org/10.1177/19458924241298817

Chicago Style (17th ed.) Citation

J, Mullur, Maurer R, Ryan T, McGill A, Bensko JC, Laidlaw TM, and Buchheit KM. "Dupilumab Treatment for Aspirin-Exacerbated Respiratory Disease in a Real-World Setting: Impact on Quality of Life and Healthcare Utilization." American Journal of Rhinology & Allergy 39, no. 2 (2025): 90. https://doi.org/10.1177/19458924241298817.

MLA (9th ed.) Citation

J, Mullur, et al. "Dupilumab Treatment for Aspirin-Exacerbated Respiratory Disease in a Real-World Setting: Impact on Quality of Life and Healthcare Utilization." American Journal of Rhinology & Allergy, vol. 39, no. 2, 2025, p. 90, https://doi.org/10.1177/19458924241298817.